CUV 1.44% $14.80 clinuvel pharmaceuticals limited

Because he does NOTHING to support valuation. Newsletters filled...

  1. 68 Posts.
    lightbulb Created with Sketch. 51
    Because he does NOTHING to support valuation. Newsletters filled with rubbish and excuses that a buy back would prevent future countries from reimbusing. Zero notable progress released to the public. Guess what Phillippe? You haven't successfully signed a new country up in years! A buyback won't set you back and further...
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.